Grant Awarded for Development of Bio-Artificial Pancreas as Cure for Type 1
  Diabetes 
From: Medical Design Technology - 09/12/2014

Beta-O2 announced today that it has received a $500K grant from JDRF. The
grant will be used to help fund a $1M pilot human study of Beta-O2's BAir
bio-artificial pancreas, in development as a treatment and potential cure for
type 1 diabetes.

Juvenile Diabetes Research Foundation (JDRF) is partnering with Beta-O2 in
order to speed up the testing of BAir, an implantable macroencapsulation
system composed of an immune protection unit (about two and a half inches
across) connected to ports through which oxygen can be periodically injected
to support the survival of the enclosed beta cells or islets.

Read the entire article at:
http://www.mdtmag.com/news/2014/09/grant-awarded-development-bio-artificial-pancreas-cure-type-1-diabetes

Links:
BetaO2 Technologies
http://beta-o2.com/

JDRF
http://jdrf.org/